| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT07668752 A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung… |
Recruitment opened |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07668752 | A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung… | KRAS G12D Mutation | Recruiting |
| NCT07262567 | Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant… | Metastatic Pancreatic Cancer | Recruiting |
| Phase 2 | |||
| NCT07554859 | GFH375 Monotherapy and Combination Therapy as First-Line Treatment for Advanced KRAS… | NSCLC (Advanced Non-small Cell Lung Cancer) | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05934513 | A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell… | Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | Recruiting |
| NCT06375733 | A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or… | Large B-cell Lymphoma | Recruiting |
| NCT06500676 | A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations | KRAS G12D Mutations | Recruiting |
| NCT07259590 | A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid… | Advanced Solid Tumors Cancer | Recruiting |
| NCT07198321 | A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients… | Cancer | Not Yet Recruiting |
| NCT07678593 | A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid… | Advanced Solid Tumors Cancer | Not Yet Recruiting |
| Phase 1 | |||
| NCT06898255 | A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or… | Cancer Cachexia | Recruiting |